Related Experiment Video
Updated: Dec 19, 2025

Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea
Published on: December 23, 2022
Diterpenoids as potential anti-inflammatory agents from Ajuga pantantha
Wenpei Liu1, Ziteng Song2, Huimei Wang1
1State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Tianjin Key Laboratory of Molecular Drug Research, and Drug Discovery Center for Infectious Disease, Nankai University, Tianjin 300350, China.
Researchers discovered five new neo-clerodane diterpenoids from Ajuga pantantha. Two compounds inhibited nitric oxide production, with one showing anti-inflammatory effects in a zebrafish model.
Area of Science:
- Natural Product Chemistry
- Medicinal Chemistry
- Pharmacology
Background:
- Phytochemical surveys aim to identify bioactive compounds from plants.
- Diterpenoids are a diverse class of natural products with various biological activities.
- Inflammation is a complex biological response implicated in many diseases.
Purpose of the Study:
- To isolate and characterize new neo-clerodane diterpenoids from Ajuga pantantha.
- To evaluate the anti-inflammatory potential of the isolated compounds.
- To elucidate the mechanism of action of the most active compounds.
Main Methods:
- Phytochemical isolation and structure elucidation using NMR spectroscopy.
- Electronic circular dichroism (ECD) calculations for absolute configuration determination.
- In vitro nitric oxide (NO) inhibition assays, molecular docking, and Western blotting.
- In vivo anti-inflammatory testing in a zebrafish model.
Main Results:
- Five new neo-clerodane diterpenoids (compounds 1-5) were identified.
- Compounds 2 and 5 demonstrated significant inhibition of NO production (IC50 < 40 μM).
- Mechanistic studies suggested anti-inflammatory properties, with compound 5 showing efficacy in vivo.
Conclusions:
- Ajuga pantantha is a source of novel bioactive neo-clerodane diterpenoids.
- Compounds 2 and 5 possess anti-inflammatory properties, warranting further investigation.
- Compound 5 shows promise as a potential anti-inflammatory agent.
Related Concept Videos
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
Plant Hormones
Antiasthma Drugs: Muscarinic Receptor Antagonists
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antiasthma Drugs: Methylxanthines
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...

